Since the role of the menisci in knee stability, proprioception, and homeostasis has been well established, significant efforts have been made to repair meniscal tears, resulting in excellent clinical outcomes and a reduction in the progression of knee osteoarthritis (OA). However, varying failure rates have been reported, raising questions regarding the healing potential in cases of complex injuries, poorly vascularized and degenerated areas, and generally in the presence of unfavorable biological characteristics. Therefore, over the last few decades, different strategies have been described to increase the chances of meniscal healing. Biological augmentation of meniscal repair through various techniques represents a safe and effective strategy with proven clinical benefits. This approach could reduce the failure rate and expand the indications for meniscal repair. In the present study, we thoroughly reviewed the available evidence on meniscal repair surgery and summarized the main techniques that can be employed to enhance the biological healing potential of a meniscal lesion. Our aim was to provide an overview of the state of the art on meniscal repair and suggest the best techniques to reduce their failure rate.

Background: Despite outstanding clinical outcomes are routinely achieved after ACL reconstruction (ACLR), the major current issue is the failure rate (re-rupture or objective clinical instability). Reinjury rates have been reported to be about 6% for ipsilateral graft rupture and 8% for contralateral ACL rupture, with a cumulative reinjury rate of about 20%. Methods: A comprehensive review of the literature was performed to summarize the latest evidence on biological, surgical and rehabilitation aspects of ACLR. Results: It has been demonstrated that young age is a risk factor for ACL graft rupture and so is not passing return-to-play (RTP) testing following ACLR (those who pass the RTP test battery have a one-third reduction in the ACL re-rupture rate). Furthermore, up to 30% of reinjury occurs within two years from ACLR. These data can be explained by numerous pieces of evidence showing that the recovery of proprioception, proper neuromuscular activation and strength, as well as proper biomechanics, remains affected for a long time after surgery (up to two or three years in some cases) despite adequate rehabilitation programs. Conclusions: Clinical evidence, together with biological data on the ligamentization process and the remodeling phase, suggest that return to strenuous sports, especially in younger athletes, should be delayed by at least 18 months or 2 years after ACLR.

Background: A knee injury in an athlete leads to periods of forced exercise interruption. Myocardial work (MW) assessed by echocardiographic and cardiopulmonary exercise testing (CPET) are two essential methods for evaluating athletes during the period following injury. However, compared to pre-surgery evaluations, the variations in cardiovascular parameters and functional capacity assessed by these methods after surgery remain unclear. Methods: We evaluated 22 non-professional athletes aged 18–52, involved in prevalently aerobic or alternate aerobic/anaerobic sports activities, who were affected by a knee pathology requiring surgical treatment. The evaluation was performed at rest using transthoracic echocardiography, including MW assessment, and during exercise using CPET. Each athlete underwent the following two evaluations: the first before surgery and the second after surgery (specifically at the end of the deconditioning period). Results: Resting heart rate (HR) increased significantly (from 63.3 ± 10.85 to 71.2 ± 12.52 beats per minute, p = 0.041), while resting diastolic and systolic blood pressure, forced vital capacity, and forced expiratory volume in the first second did not show significant changes. Regarding the echocardiographic data, global longitudinal strain decreased from −18.9 ± 1.8 to −19.3 ± 1.75; however, this reduction was not statistically significant (p = 0.161). However, the global work efficiency (GWE) increased significantly (from 93.0% ± 2.9 to 94.8% ± 2.6, p = 0.006) and global wasted work (GWW) reduced significantly (from 141.4 ± 74.07 to 98.0 ± 50.9, p = 0.007). Additionally, the patients were able to perform maximal CPET at both pre- and post-surgery evaluations, as demonstrated by the peak respiratory exchange ratio and HR. However, the improved myocardial contractility (increased GWE and decreased GWW) observed at rest did not translate into significant changes in exercise parameters, such as peak oxygen consumption and the mean ventilation/carbon dioxide slope. Conclusions: After surgery, the athletes were more deconditioned (as indicated by a higher resting HR) but exhibited better resting myocardial contractility (increased GWE and reduced GWW). Interestingly, no significant changes in exercise capacity parameters, as evaluated by CPET, were found after surgery, suggesting that the improved myocardial contractility was offset by a greater degree of muscular deconditioning.

Purpose: Sarcopenia has emerged as a potential prognostic factor for postoperative complications, functional recovery, patient-reported outcomes, and healthcare costs in patients undergoing total knee arthroplasty (TKA). This systematic review aimed to evaluate its impact on these outcomes following primary TKA. Methods: A systematic review was conducted according to PRISMA guidelines and prospectively registered in PROSPERO (CRD420261320013). PubMed/MEDLINE, EMBASE, and Cochrane Library were searched up to 1 December 2025. Comparative clinical studies including sarcopenic and non-sarcopenic patients undergoing primary TKA and reporting postoperative outcomes were included. Methodological quality was assessed using the MINORS tool. Due to heterogeneity in study design, diagnostic criteria, and outcome measures, a narrative synthesis was performed. Results: Nine studies including more than 93,000 patients were analyzed. Sarcopenia prevalence ranged from 7.7% to 25%. Sarcopenic patients demonstrated higher rates of postoperative complications, including medical events, blood transfusion, falls, fractures, reoperations, and implant-related complications. Functional recovery was delayed, particularly in patients with sarcopenic obesity, with slower improvements in range of motion and gait speed. Although both groups improved after TKA, short- to mid-term patient-reported outcomes were often inferior in sarcopenic patients, while long-term differences were less consistent. Sarcopenia was also associated with longer hospital stay and increased healthcare costs. Conclusions: Sarcopenia is associated with worse postoperative outcomes following primary TKA and may represent a modifiable risk factor for perioperative optimization.